Prostate Cancer Patient Guide
PCF's Prostate Cancer Patient Guide is compiled with the contributions of top-tier doctors and researchers in prostate cancer, and is a must-have resource for patients and families. It focuses all of the information available about contemporary prostate cancer research, treatment, and lifestyle factors into one consolidated document. It is for. Read More
03/23/2022
Breaking News: First-in-Class Radioligand Therapy Approved for Advanced Prostate Cancer
What this means for patients: Today, a new treatment known as 177lutetium-PSMA-617 (Lu-PSMA; trade name Pluvicto®) was approved by the FDA for certain patients with advanced prostate cancer. This medicine delivers a small dose of radiation attached to a molecule that specifically binds to prostate cancer cells. It has been shown to. Read More
How PCF is Furthering Health Equity and Combating Prostate Cancer Disparities
In the U.S., 1 in 8 men in their lifetime will be diagnosed with prostate cancer. But the disease does not affect all men equally. 1 in 6 Black men will be diagnosed with prostate cancer in their lifetime and they are more than 2 times as likely to die. Read More
03/22/2022
Roasted Spring Brussels Sprouts
It’s spring. That means the grocery stores will begin to fill with a glorious abundance of seasonal fruits and vegetables. For some, April also means a family gathering filled with traditional Easter dishes and Easter bunny treats. Whether you celebrate Easter or just worship the leaves and flowers popping through. Read More
03/21/2022
Guía para pacientes con cáncer de próstata | Prostate Cancer Patient Guide
La guía más reciente de la Fundación contra el Cáncer de Próstata es para pacientes que prefieren leer en español. Se basa en nuestra guía completa para pacientes con cáncer de próstata, compilada con las contribuciones de médicos e investigadores expertos, y en nuestra guía para la salud y el. Read More
03/15/2022
Millions in New Federal Funding for Prostate Cancer Research
Today President Biden signed into law H.R. 2471, the “Consolidated Appropriations Act, 2022”, which was passed by the House and Senate last week. The omnibus package notably includes: $110 million for the Peer-reviewed Prostate Cancer Research Program at the Department of Defense $14.2 million for Prostate Cancer at the Centers. Read More
03/09/2022
“There’s Still A Lot We Can Do”
PCF thanks Mr. Merzer for sharing his personal story, and for his dedication and support during the 100 Miles in March walking challenge. It is inevitable. It is part of life. It is how it all works. Sooner or later, preferably later and not frequently, bad news arrives. For me. Read More
03/08/2022
Highlights of ASCO GU 2022, Part 1
Combination treatments for metastatic disease Clinicians and researchers gathered last month at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) — some in-person in San Francisco, some tuning in virtually. Hundreds of presentations covered advances in screening, diagnosis, treatment, monitoring, and survivorship in prostate and other GU. Read More
03/08/2022
Less Meat, Less Prostate Cancer?
People often have questions about whether specific foods—such as meat—might increase their risk of prostate cancer or other diseases. A new study of more than 200,000 men in the U.K. found that men who were vegetarian, and men who ate fish (but no meat), were less likely to be diagnosed. Read More
03/01/2022
DIY Home Fitness: Work with What You Have, Start Small, and Do Great Things
Many people start an exercise program with the idea, “Go big or go home.” They set overambitious goals, or start out trying to do too much, too fast, and they quit after a few weeks. You don’t have to do that, says PCF-funded Harvard scientist Christina Dieli-Conwright, Ph.D., M.P.H. If. Read More